R.J.A. Diepersloot - Concepedia

Author

R.J.A. Diepersloot

Also Known As

Diepersloot, Rob, J C Dutilh, Ph. G. de Groot, R J A Diepersloot, R J Diepersloot, R. J. A. Diepersloot, R.J.A. Diepersloot, ROB J.A. DIEPERSLOOT, Rob Diepersloot, Rob J A Diepersloot

Publications

892

Citations

H-Index

Concepts

All Affiliations

Diakonessenhuis hospital University Medical Center Utrecht Utrecht University Jeroen Bosch Ziekenhuis Erasmus University Rotterdam

About

R.J.A. Diepersloot is an author at Diakonessenhuis hospital specializing in medicine, immunology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	399
2	Diabetes	5	5	164
3	Health Sciences	3	3	112
4	Public Health	2	2	97
5	Epidemiology	2	2	97

R.J.A. Diepersloot

Publications

625

Citations

H-Index

Page 1

	Year	Citations
Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976–1979 in The Netherlands K.P. Bouter, R.J.A. Diepersloot, L. K. J. van Romunde, Diabetes Research and Clinical Practice Infectious Disease EpidemiologyEpidemiological TrendDiabetesClinical EpidemiologyEpidemic Influenza	1991	66
Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A Frank L.J. Visseren, M.S.A. Verkerk, Tjomme van der Bruggen, European Journal of Clinical Investigation	2002	64
Infection-induced inflammatory response of adipocytes in vitro John J. M. Bouwman, Frank L.J. Visseren, K.P. Bouter, International Journal of Obesity InflammationHost ResponseAutoimmune DiseaseImmunologyChronic Inflammation	2008	61
Management of an outbreak of Enterobacter cloacae in a neonatal unit using simple preventive measures Yvonne van Dijk, Elisabeth M. Bik, S. Hochstenbach-Vernooij, Journal of Hospital Infection Simple Preventive MeasuresHealth SciencesPathogen DetectionHealthcare-associated InfectionPediatrics	2002	49
Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus Frank L.J. Visseren, M.S.A. Verkerk, K.P. Bouter, Journal of Laboratory and Clinical Medicine InflammationCytokineEndothelial CellsImmunologyViral Pathogenesis	1999	47
Tissue Concentrations after a Single-Dose, Orally Administered Ofloxacin in Patients with Diabetic Foot Infections Emile M. Kuck, K.P. Bouter, J. B. L. Hoekstra, Foot & Ankle International	1998	35
Humoral Immune Response to a Yeast‐derived Hepatitis B Vaccine in Patients with Type 1 Diabetes Mellitus K.P. Bouter, R.J.A. Diepersloot, Pieter J. Wismans, Diabetic Medicine	1992	34
Piperacillin/Tazobactam Therapy for Diabetic Foot Infection Anneke M. Zeillemaker, Karin‐Ellen Veldkamp, Marian G.J. van Kraaij, Foot & Ankle International Adverse EventsHealth SciencesAntibioticsDiabetesPharmacology	1998	32
Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics Cornelis H. van Werkhoven, Jan van der Tempel, Rana Jajou, Clinical Microbiology and Infection Preventive MedicineAntibioticsClostridium Difficile InfectionDisease Risk AssessmentHealthcare-associated Infection	2015	31
Influence of blood glucose levels on peripheral lymphocytes in patients with diabetes mellitus. K.P. Bouter, Frits H.J. Gmelig Meyling, J.B.L. Hoekstra, PubMed T-cell PopulationPeripheral LymphocytesImmunologyPathologyImmunotherapy	1992	31

Page 1